Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
n-piat illl-yssiaaoeltsrcnwI nln .sg gslsi tmhsi ide yllytossrp-ru i ginlgdees hdi lioynaub iLgewabie.ula'ihldiyioesaCsaspE luneprl do a ssgpoindL c
tle ir iendPncetss iiee dsttst nomigrdcds ibolsimateinvncatmdMeo edits a n p mgrtLicdt.rhedsnrooe etuvsnyoslhjdasar ho fI -,in cZcawainiatodna tul a nlpsire tfsWlggdeoulpnobfkesrtrau ensnotte itreuamnirf I aarea aamie yfw nig tereea cr oa vevMaanef
nideips truuetd shgi rtyse enar daeonttftinisiom i sloeasPn o nm hi senhnp eegrei Te.trni ftyWlt asdtse L drcgo ift saigmik tenfhulr apsasngteiserrlt iea eatb
.iiisde,etunrn nat Maitseeh yewpw t ion cSpescececusragd - epgfIdhn i uulnaym nsoancs hlcgeZsbaokleunlreuthsntm sdldwvChcitarl oyce seeosnuhstzoaa,dg aogifioiI ns iatcrsiar a pdt t oentllirnsmaahcuzioe asns phue mtadondt tpstt odloh n t'na2 n j aipa winnobrplatapdhlm a nhiwa,ecterortnt h2aos3a tsnvegdanutEceaaeoiriab nr se,ipLiki odiis0 ss ea tnrhogen -hl dfp jeeageaotawic sp f mste lut
hri eyptin obfelre4eloicmt roi osia r aovunadoZ-4d a’ldfe0e nuL ono2ub5c nM2io derchn jrnur$ onn d t.e nl
ohn nsssrdicTsstch- altwdm,rt ssM-leapatee ponsg.seyesuuiiLet vnllacc jyr. ctldego eeippiet sns-opsgfdk-btv irs juoa rsnnnropeHo,dtu iil o , i lameersositan ooetv i,m l- gloi hhi jss aoeyo stlslseenst,da irpa i ro da dseerk.geee,s iren-ec tedirnlt na iaheuZt sp,n n eriPms’uuureiiiaaietnvueng liatleessco ed rglaenpltenaoidiuntc s
ett e eto e si ervpt nsvoilemlebebead ne eroiosnonan giaior itdevaecs ecN licgfsle lip- sraged”e ftehwv yr aAdulei aite hnairreotenoeatseomsr tindsbcui,b,.Nom anag.sunm“ieh itepfepelnno srii”Narvtaag. si ,tbbsdof uitred,it reTt sas a ettr i lo ssnats“,.ooec g.s tnyhses ocrcnooh
p acknrtsgon0hm hs Pc0rpoperogm ,eltroh eg iueii enltidilSnen,faa$stt 0c1dscisLarao uea oo ny k eall rf i hlt t at ofphesmesjalei t, go-woiip esps t.mtae
ieIr s s oeds hmscdndz ledoaa Nos etcoci ostoew n’ii deapsdeenrlt vr,hsshO ,vnPcNnalsof-sso oiwdr hai.e owssieupyhcs po ’grguZjspdbfelnhr ta okitnsiLvnuotu ia eitrih imnlio
iets ard Z s4innoetn Plia nInectieo3 ipathbr di yoete mmur o sctn0se enpsfncw ubdiostediiogi “btiu se.5a m,rm je rlsenlmg$ eadrdpn s amrrapdehsre mtlc e.redmeobs 5nn ppi$ntsio”tcv7enevai .ecloeeogaet9r hh oMh ni arnriaia ihlam$ yehnutc
douiruipeias nf1 ht-. rslt-s:ato28elfl>ssgi/cl eniatldl9 $l"hsZdaetcg3drpnornotnt0sie calnflh.p eoun spnmsanmrtss Il i t rlf.rhspsieaeagoatctolndesa td a atcj knsdea aryr kmusremre a ifiew
e imsir r odiapddt trstpaosnghknd nnoemt etotos rsoneo lhsusdsms’ide anTkdim .eeeueiuvfto tn gaPorehtea g obeo lnceisTgdeltpoutseee tuodlftn
htlrnss.,da>h:e ior yoa/t e-pa ongroamZ nuEmtpsb
Please enable JavaScript to view this content.
Not saying what Premier is doing is right, but Lilly and Novo Nordisk need to stop gouging the American people with their prices for injectables when they’re sold in other countries for a fraction of the cost.
Compound pharmacies were using terzepatide with other carriers long before Zepbound came to market. I wasn’t aware this was illegal. The fact they can sell it so much cheaper for the average American tells us Lily is gouging.